Likuiditas cepet PepGen Inc (PEPG)

Simbol lan logo merek PepGen Inc. (PEPG)

The price trend for PepGen Inc. (PEPG) reflects a value of 13.32. The business focuses on developing therapies for muscle pathologies, where research and development costs keep operating efficiency in negative territory. The team consists of top geneticists attracted by innovative projects and stock option programs. High salaries and academic freedom help the company retain first-class biochemists developing neuromuscular treatments.

PepGen (PEPG) - Likuiditas darurat saka 28.04.2023 nganti 29.10.2026
Barang unggulan PepGen Inc.

This indicator reflects operational resilience by measuring the company's ability to cover short-term liabilities using cash and accounts receivable, excluding low-liquidity inventories. For PepGen Inc. (PEPG), which focuses on costly clinical trials for neuromuscular pathology drugs, this metric is critical for assessing financial autonomy, clearly demonstrating the quick liquidity trend.

Pesaing wigati

Biogen Corp (BIIB) - Likuiditas cepet|Likuiditas darurat Neurocrine Corp (NBIX)|Likuiditas cepet Regencell Bioscience|axsome.com - Rasio likuiditas kritis|Rasio cepet ACAD|XENE - Likuiditas darurat|Likuiditas cepet Viking Pharma VKTX|SUPN (Supernus Corp) - Rasio likuiditas kritis|Catalyst Pharmaceuticals - Rasio cepet|Likuiditas kritis denalitherapeutics.com (DNLI)|HRMY: Rasio cepet|Likuiditas darurat Biohaven Ltd (BHVN)|Likuiditas cepet Amylyx|Rasio likuiditas darurat TRVI (Trevi Corp)|Indikator likuiditas cepet PRAX (Praxis Precision Medicines)|AVXL (anavex.com) - Rasio jangkoan perantara|Rasio cepet CBLL (CeriBell)|Koefisien jangkoan perantara Prothena Corp (PRTA)|ALEC - Likuiditas cepet|ANNX (Annexon Biosciences Inc.) - Rasio likuiditas darurat|OMER: Rasio cepet|Indikator likuiditas cepet neurogene.com|Indikator likuiditas cepet ACIU|Voyager Therapeutics Inc (VYGR) - Koefisien jangkoan perantara|Likuiditas cepet Neumora Therapeutics Inc (NMRA)|SCLX: Rasio likuiditas kritis|Rasio cepet TVGN (Tevogen Bio Holdings)|Alpha Cognition Inc (ACOG) - Likuiditas darurat|CGTX - Likuiditas cepet|Rasio likuiditas kritis IKT|SAVA: Rasio cepet|Likuiditas kritis Assertio ASRT|Likuiditas cepet Coya Therapeutics Inc|Rasio likuiditas darurat VTGN (VistaGen Therapeutics Inc)|Rasio cepet OVID|ABOS - Likuiditas darurat|CervoMed Inc - Indikator likuiditas cepet|Rasio cepet Alterity Therapeutics Ltd. ATHE|CLNN - Likuiditas cepet|Rasio jangkoan perantara JUNS (Jupiter Neurosciences, Inc.)|Relmada Therapeutics, Inc. (RLMD) - Likuiditas cepet|Likuiditas darurat Annovis Bio Inc (ANVS)|Likuiditas cepet Grace Therapeutics Inc|Firefly Neuro - Rasio likuiditas kritis|Rasio cepet KLTO|NRSN - Likuiditas darurat|Likuiditas cepet Reviva Pharmaceuticals Holdings, Inc. RVPH|MTVA (MetaVia Inc.) - Rasio likuiditas kritis|NeurAxis, Inc - Rasio cepet|Likuiditas kritis Helius Medical (HSDT)|PASG: Rasio cepet|Likuiditas darurat Neuphoria Therapeutics (NEUP)|Likuiditas cepet Minerva Neurosciences, Inc.|Rasio likuiditas darurat ATHA (Athira Pharma Inc)|Indikator likuiditas cepet ADXN (Addex Therapeutics, Ltd.)|ALZN (alzamend.com) - Rasio jangkoan perantara|Rasio cepet CYCN (Cyclerion Therapeutics, Inc.)|Koefisien jangkoan perantara Protagenic Therapeutics Inc. (PTIX)|KTTA - Likuiditas cepet|CRGT (Cortigent, Inc.) - Rasio likuiditas darurat|ATXI: Rasio cepet|Indikator likuiditas cepet BrainStorm Cell Therapeutics Inc.|Indikator likuiditas cepet CARA|chromocell.com (CHRO) - Koefisien jangkoan perantara|Likuiditas cepet Eliem Therapeutics (ELYM)|ITCI: Rasio likuiditas kritis|Rasio cepet LBPH (Longboard Pharma)|Marinus Pharma (MRNS) - Likuiditas darurat|NKGN - Likuiditas cepet|Rasio likuiditas kritis NRBO|SAGE: Rasio cepet|Likuiditas kritis Synaptogenix Inc. SNPX|Likuiditas cepet Trevena, Inc|Rasio likuiditas darurat VIGL (Vigil Neuro)|Rasio cepet WENA|CERE - Likuiditas darurat